Soligenix to Present at BIO CEO & Investor Conference
Hand-out
Press Releases
February 4, 2025

Soligenix to Present at BIO CEO & Investor Conference

PRINCETON, N.J., Feb. 4, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where

bradford

The Bradford Era

Local & Social